Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 4;61(4):585–589. doi: 10.2169/internalmedicine.7971-21

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 by The Japanese Society of Internal Medicine

The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 3. — Clinical course of the patient. The patient was treated with dexamethasone (6 mg/day) and remdesivir, followed by methylprednisolone (mPSL) 125 mg/day. On day 8, a pulsed dose of mPSL (1,000 mg/day) was started, since respiratory failure had progressed. On day 20, tacrolimus treatment was started. Doses of prednisolone (PSL) were tapered after starting tacrolimus. On day 78, the patient was discharged with 15 mg/day of PSL and 4 mg/day of tacrolimus with home oxygen therapy on exertion.